VitalFlo

VitalFlo, founded in 2017 and headquartered in the United States, aims to revolutionize respiratory patient management. The company's slogan "VitalFlo's mission is to make respiratory patient management easy, reduce cost of care, and improve patient outcomes" underscores its commitment to transforming healthcare delivery. VitalFlo's innovative approach involves assisting doctors in measuring, monitoring, and predicting their patients' lung health using a software and data platform. This enables primary care physicians to conduct spirometry efficiently, benefiting both asthma and COPD patients in any setting - whether in-clinic or at-home. This streamlined process not only enhances patient care but also reduces clinical time spent per test while increasing revenue for providers through existing insurance reimbursement codes. In April 2023, VitalFlo secured a significant Seed Round investment from Triangle Tweener Fund. This funding is a testament to the confidence that investors have in the potential of VitalFlo's solution to revolutionize respiratory patient management. The financial support from Triangle Tweener Fund underscores industry recognition of VitalFlo's value proposition and its potential to address critical challenges within the healthcare sector. VitalFlo's cutting-edge technology, coupled with its recent investment infusion, positions the company well to disrupt and improve respiratory patient management. The collaboration with Triangle Tweener Fund not only provides essential financial backing but also opens doors for strategic partnerships and further growth opportunities. As VitalFlo continues to evolve and expand its reach, it stands poised to make a lasting impact on the healthcare industry by enhancing patient outcomes and reducing the cost of care.